Factors Influencing Culture Outcomes in Patients with Persistent Smear-Positive Pulmonary Tuberculosis After Two Months of Treatment - Report - MDSpire

Factors Influencing Culture Outcomes in Patients with Persistent Smear-Positive Pulmonary Tuberculosis After Two Months of Treatment

  • By

  • Junais Koleri

  • Faraj S. Howady

  • Jay P. N. Singh

  • Sara Al Balushi

  • Muna Al Maslamani

  • January 23, 2026

  • 0 min

Share

Factors Influencing Culture Outcomes in Patients with Persistent Smear-Positive Pulmonary Tuberculosis After Two Months of Treatment

Overview

This study investigates the culture status of patients with persistent smear-positive pulmonary tuberculosis after two months of treatment. It identifies factors that predict culture-negative status, aiming to refine isolation guidelines and improve patient management.

Background

Pulmonary tuberculosis (TB) remains a significant global health issue, with varying guidelines for respiratory isolation duration. Patients who remain smear-positive after two months of treatment may experience unnecessary isolation, leading to psychological and socioeconomic challenges. Understanding the factors influencing culture outcomes is crucial for optimizing treatment and isolation protocols.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

Rephrase findings for clarity and ensure they are supported by the study's data.

Clinical Implications

Clinicians should consider both smear and culture results when making isolation decisions for TB patients. Understanding the predictors of culture outcomes can help tailor treatment and reduce unnecessary isolation, ultimately improving patient well-being.

Conclusion

This study highlights the need for refined isolation guidelines based on culture outcomes in smear-positive TB patients. Balancing infection control with patient care is essential for effective TB management.

References

  1. Open Forum Infectious Diseases, 2023 -- Efficacy of a Daily Two-Drug Regimen of Macrolide and Ethambutol in Managing Mycobacterium avium Complex Pulmonary Disease
  2. Open Forum Infectious Diseases, 2023 -- Impact of Specific Medications on Time to Culture Conversion in Pulmonary Disease Caused by Mycobacterium avium Complex
  3. Open Forum Infectious Diseases, 2023 -- Impact of Culture Conversion Timing on Clinical Outcomes in Mycobacterium Avium Complex Pulmonary Disease
  4. The Journal of Infectious Diseases, 2023 -- Assessing Infectiousness and the Impact of Effective Treatment to Guide Isolation Recommendations for People With Pulmonary Tuberculosis
  5. ATS/CDC/ERS/IDSA, 2025 -- Clinical Practice Guideline Update on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis
  6. Predictors of culture status in patients with persistent smear-positive pulmonary tuberculosis at two months of treatment - PMC
  7. Quantifying the contribution of smear-negative, culture-positive pulmonary tuberculosis to nosocomial transmission - PubMed
  8. ATS/CDC/ERS/IDSA Clinical Practice Guideline Update on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis
  9. Predictors of culture status in patients with persistent smear-positive pulmonary tuberculosis at two months of treatment - PMC
  10. Quantifying the contribution of smear-negative, culture-positive pulmonary tuberculosis to nosocomial transmission - PubMed

Original Source(s)

Related Content